Heterogeneity of executive function revealed by a functional random forest approach across ADHD and ASD.


Journal

NeuroImage. Clinical
ISSN: 2213-1582
Titre abrégé: Neuroimage Clin
Pays: Netherlands
ID NLM: 101597070

Informations de publication

Date de publication:
2020
Historique:
received: 08 11 2019
revised: 12 03 2020
accepted: 14 03 2020
pubmed: 29 3 2020
medline: 23 2 2021
entrez: 29 3 2020
Statut: ppublish

Résumé

Those with autism spectrum disorder (ASD) and/or attention-deficit-hyperactivity disorder (ADHD) exhibit symptoms of hyperactivity and inattention, causing significant hardships for families and society. A potential mechanism involved in these conditions is atypical executive function (EF). Inconsistent findings highlight that EF features may be shared or distinct across ADHD and ASD. With ADHD and ASD each also being heterogeneous, we hypothesized that there may be nested subgroups across disorders with shared or unique underlying mechanisms. Participants (N = 130) included adolescents aged 7-16 with ASD (n = 64) and ADHD (n = 66). Typically developing (TD) participants (n = 28) were included for a comparative secondary sub-group analysis. Parents completed the K-SADS and youth completed an extended battery of executive and other cognitive measures. A two stage hybrid machine learning tool called functional random forest (FRF) was applied as a classification approach and then subsequently to subgroup identification. We input 43 EF variables to the classification step, a supervised random forest procedure in which the features estimated either hyperactive or inattentive ADHD symptoms per model. The FRF then produced proximity matrices and identified optimal subgroups via the infomap algorithm (a type of community detection derived from graph theory). Resting state functional connectivity MRI (rs-fMRI) was used to evaluate the neurobiological validity of the resulting subgroups. Both hyperactive (Mean absolute error (MAE) = 0.72, Null model MAE = 0.8826, (t(58) = -4.9, p < .001) and inattentive (MAE = 0.7, Null model MAE = 0.85, t(58) = -4.4, p < .001) symptoms were predicted better than chance by the EF features selected. Subgroup identification was robust (Hyperactive: Q = 0.2356, p < .001; Inattentive: Q = 0.2350, p < .001). Two subgroups representing severe and mild symptomology were identified for each symptom domain. Neuroimaging data revealed that the subgroups and TD participants significantly differed within and between multiple functional brain networks, but no consistent "severity" patterns of over or under connectivity were observed between subgroups and TD. The FRF estimated hyperactive/inattentive symptoms and identified 2 distinct subgroups per model, revealing distinct neurocognitive profiles of Severe and Mild EF performance per model. Differences in functional connectivity between subgroups did not appear to follow a severity pattern based on symptom expression, suggesting a more complex mechanistic interaction that cannot be attributed to symptom presentation alone.

Sections du résumé

BACKGROUND
Those with autism spectrum disorder (ASD) and/or attention-deficit-hyperactivity disorder (ADHD) exhibit symptoms of hyperactivity and inattention, causing significant hardships for families and society. A potential mechanism involved in these conditions is atypical executive function (EF). Inconsistent findings highlight that EF features may be shared or distinct across ADHD and ASD. With ADHD and ASD each also being heterogeneous, we hypothesized that there may be nested subgroups across disorders with shared or unique underlying mechanisms.
METHODS
Participants (N = 130) included adolescents aged 7-16 with ASD (n = 64) and ADHD (n = 66). Typically developing (TD) participants (n = 28) were included for a comparative secondary sub-group analysis. Parents completed the K-SADS and youth completed an extended battery of executive and other cognitive measures. A two stage hybrid machine learning tool called functional random forest (FRF) was applied as a classification approach and then subsequently to subgroup identification. We input 43 EF variables to the classification step, a supervised random forest procedure in which the features estimated either hyperactive or inattentive ADHD symptoms per model. The FRF then produced proximity matrices and identified optimal subgroups via the infomap algorithm (a type of community detection derived from graph theory). Resting state functional connectivity MRI (rs-fMRI) was used to evaluate the neurobiological validity of the resulting subgroups.
RESULTS
Both hyperactive (Mean absolute error (MAE) = 0.72, Null model MAE = 0.8826, (t(58) = -4.9, p < .001) and inattentive (MAE = 0.7, Null model MAE = 0.85, t(58) = -4.4, p < .001) symptoms were predicted better than chance by the EF features selected. Subgroup identification was robust (Hyperactive: Q = 0.2356, p < .001; Inattentive: Q = 0.2350, p < .001). Two subgroups representing severe and mild symptomology were identified for each symptom domain. Neuroimaging data revealed that the subgroups and TD participants significantly differed within and between multiple functional brain networks, but no consistent "severity" patterns of over or under connectivity were observed between subgroups and TD.
CONCLUSION
The FRF estimated hyperactive/inattentive symptoms and identified 2 distinct subgroups per model, revealing distinct neurocognitive profiles of Severe and Mild EF performance per model. Differences in functional connectivity between subgroups did not appear to follow a severity pattern based on symptom expression, suggesting a more complex mechanistic interaction that cannot be attributed to symptom presentation alone.

Identifiants

pubmed: 32217469
pii: S2213-1582(20)30082-6
doi: 10.1016/j.nicl.2020.102245
pmc: PMC7109457
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

102245

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH086654
Pays : United States
Organisme : NIMH NIH HHS
ID : R37 MH059105
Pays : United States
Organisme : NIDA NIH HHS
ID : P50 DA048756
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH096773
Pays : United States
Organisme : NIMH NIH HHS
ID : K99 MH091238
Pays : United States
Organisme : NIMH NIH HHS
ID : R00 MH091238
Pays : United States
Organisme : NIDA NIH HHS
ID : U01 DA041148
Pays : United States
Organisme : NLM NIH HHS
ID : T15 LM007088
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH115357
Pays : United States

Informations de copyright

Copyright © 2020. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors Cordova, M., Shada, K., Demeter, D.V., Doyle, O., Miranda-Dominguez, O., Perrone, A., Schifsky, E., Graham, A., Langhorst, B., Nigg, J., Fombonne, E., Fair, D.A., Feczko, E. have no financial disclosures or conflicts to declare.

Références

Biol Psychiatry. 2010 Dec 15;68(12):1114-9
pubmed: 20926067
J Child Psychol Psychiatry. 2020 Jan;61(1):51-61
pubmed: 31509248
Proc Natl Acad Sci U S A. 2007 Aug 14;104(33):13507-12
pubmed: 17679691
Trends Cogn Sci. 2018 Mar;22(3):241-257
pubmed: 29475637
Clin Psychol Rev. 2010 Dec;30(8):951-61
pubmed: 20659781
Neuropsychology. 2012 Nov;26(6):684-94
pubmed: 23106115
J Child Psychol Psychiatry. 1996 Jan;37(1):51-87
pubmed: 8655658
Clin Psychol Rev. 2008 Apr;28(4):692-708
pubmed: 18036711
J Am Acad Child Adolesc Psychiatry. 1997 Jul;36(7):980-8
pubmed: 9204677
Psychiatry Res. 2009 Apr 30;166(2-3):210-22
pubmed: 19285351
Cereb Cortex. 2017 Mar 1;27(3):1709-1720
pubmed: 28062515
Hum Brain Mapp. 2014 Dec;35(12):6032-48
pubmed: 25116862
Proc Natl Acad Sci U S A. 2007 Jun 26;104(26):11073-8
pubmed: 17576922
Nat Rev Neurosci. 2009 Nov;10(11):792-802
pubmed: 19812579
Neuroimage Clin. 2019;21:101678
pubmed: 30708240
J Int Neuropsychol Soc. 2015 Apr;21(4):271-84
pubmed: 25928822
Neuroimage Clin. 2019;21:101601
pubmed: 30497980
Nat Rev Neurosci. 2002 Mar;3(3):201-15
pubmed: 11994752
Psychol Med. 2010 Jan;40(1):159-66
pubmed: 19490743
J Neurosci. 2007 Feb 28;27(9):2349-56
pubmed: 17329432
J Am Acad Child Adolesc Psychiatry. 2012 Oct;51(10):990-1002.e2
pubmed: 23021476
Front Neurosci. 2014 Jun 11;8:150
pubmed: 24966810
Front Hum Neurosci. 2014 Apr 29;8:268
pubmed: 24808851
Transl Psychiatry. 2016 Feb 09;6:e732
pubmed: 26859815
Trends Cogn Sci. 2019 Jul;23(7):584-601
pubmed: 31153774
JAMA Pediatr. 2019 Feb 1;173(2):147-152
pubmed: 30535156
Annu Rev Psychol. 2013;64:135-68
pubmed: 23020641
Proc Natl Acad Sci U S A. 2012 Apr 24;109(17):6769-74
pubmed: 22474392
Neuroimage. 2015 Feb 15;107:146-162
pubmed: 25482265
J Abnorm Psychol. 2012 Nov;121(4):991-1010
pubmed: 22612200
Nat Rev Neurosci. 2003 Oct;4(10):829-39
pubmed: 14523382
Biol Psychiatry. 2005 Jun 1;57(11):1336-46
pubmed: 15950006
Biol Psychiatry. 2005 Jun 1;57(11):1424-35
pubmed: 15950017
Neuron. 2017 Jul 19;95(2):457-471.e5
pubmed: 28728026
Mol Psychiatry. 2011 Nov;16(11):1147-54
pubmed: 20856250
Trends Cogn Sci. 2006 Mar;10(3):117-23
pubmed: 16460990
J Abnorm Child Psychol. 1999 Oct;27(5):393-402
pubmed: 10582840
J Atten Disord. 2020 Jan;24(1):41-51
pubmed: 30296883
Nat Neurosci. 2015 Aug;18(8):1143-51
pubmed: 26147532
Cogn Psychol. 2000 Aug;41(1):49-100
pubmed: 10945922
Behav Brain Funct. 2005 Jul 20;1(1):10
pubmed: 16033644
J Neurosci. 2011 Mar 2;31(9):3217-24
pubmed: 21368033
J Child Psychol Psychiatry. 2004 May;45(4):836-54
pubmed: 15056314
Neuroimage. 2013 Oct 15;80:105-24
pubmed: 23668970
Dementia. 1994 Sep-Oct;5(5):266-81
pubmed: 7951684
Netw Neurosci. 2018 Jun 01;2(2):200-217
pubmed: 30215033
J Atten Disord. 2017 Aug;21(10):846-855
pubmed: 25085653
Child Adolesc Psychiatry Ment Health. 2008 Jan 31;2(1):4
pubmed: 18237439
Brain Struct Funct. 2017 Dec;222(9):3973-3990
pubmed: 28551777
JAMA Psychiatry. 2014 Sep;71(9):1015-24
pubmed: 25006969
Proc Natl Acad Sci U S A. 2005 Jul 5;102(27):9673-8
pubmed: 15976020
J Child Psychol Psychiatry. 2006 Mar-Apr;47(3-4):395-422
pubmed: 16492265
J Abnorm Child Psychol. 2018 Nov;46(8):1705-1716
pubmed: 29450820
Cereb Cortex. 2016 Jan;26(1):288-303
pubmed: 25316338
Proc Natl Acad Sci U S A. 2008 Jan 29;105(4):1118-23
pubmed: 18216267
PLoS One. 2016 Apr 11;11(4):e0153331
pubmed: 27065101
Mol Psychiatry. 2019 Oct;24(10):1435-1450
pubmed: 30617272
J Am Acad Child Adolesc Psychiatry. 2010 Apr;49(4):345-55
pubmed: 20410727
Cost Eff Resour Alloc. 2005 Jun 09;3:5
pubmed: 15946385
J Abnorm Child Psychol. 2010 Feb;38(2):149-61
pubmed: 19787447
Neuron. 2011 Nov 17;72(4):665-78
pubmed: 22099467
Hum Brain Mapp. 2014 May;35(5):1981-96
pubmed: 23861343
J Child Psychol Psychiatry. 2007 Nov;48(11):1061-70
pubmed: 17995481
Arch Clin Neuropsychol. 2008 Mar;23(2):201-16
pubmed: 18096360
Res Dev Disabil. 2018 Dec;83:260-269
pubmed: 30368089
Neuroimage. 2018 May 15;172:674-688
pubmed: 29274502
J Am Acad Child Adolesc Psychiatry. 2018 Apr;57(4):252-262.e4
pubmed: 29588051
Psychol Med. 2009 Nov;39(11):1895-906
pubmed: 19335935
J Am Acad Child Adolesc Psychiatry. 2007 Nov;46(11):1437-44
pubmed: 18049293
J Neural Transm (Vienna). 2017 Feb;124(2):259-271
pubmed: 28000020
J Abnorm Psychol. 2012 May;121(2):360-71
pubmed: 22428793
Expert Rev Neurother. 2008 Apr;8(4):657-69
pubmed: 18416666
Psychol Bull. 1997 Jan;121(1):65-94
pubmed: 9000892
J Child Psychol Psychiatry. 2014 Jul;55(7):819-27
pubmed: 24444366
J Abnorm Child Psychol. 2009 Apr;37(3):337-48
pubmed: 18668361
J Autism Dev Disord. 2010 Aug;40(8):1017-27
pubmed: 20140638
Int Rev Neurobiol. 2011;101:1-17
pubmed: 22050846
Dev Cogn Neurosci. 2015 Feb;11:155-74
pubmed: 25660033
Cortex. 2017 Jan;86:186-204
pubmed: 27251123

Auteurs

Michaela Cordova (M)

Department of Behavioral Neuroscience, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97221, USA. Electronic address: cordova@ohsu.edu.

Kiryl Shada (K)

Division of Developmental/Behavioral Pediatrics and Psychology; Rainbow Babies & Children's Hospital, 11100 Euclid Ave., Cleveland, OH 44106, USA. Electronic address: Kiryl.Shada@UHhospitals.org.

Damion V Demeter (DV)

Department of Psychology; U. Texas Austin, Austin, TX; University of Texas at Austin, 108 E Dean Keeton St., Austin, TX 78712, USA. Electronic address: demeter@utexas.edu.

Olivia Doyle (O)

Department of Behavioral Neuroscience, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97221, USA. Electronic address: doyleo@ohsu.edu.

Oscar Miranda-Dominguez (O)

Department of Behavioral Neuroscience, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97221, USA. Electronic address: mirandad@ohsu.edu.

Anders Perrone (A)

Department of Behavioral Neuroscience, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97221, USA. Electronic address: perronea@ohsu.edu.

Emma Schifsky (E)

Department of Behavioral Neuroscience, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97221, USA.

Alice Graham (A)

Department of Behavioral Neuroscience, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97221, USA; Department of Psychiatry, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97221, USA. Electronic address: grahaal@ohsu.edu.

Eric Fombonne (E)

Department of Psychiatry, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97221, USA. Electronic address: fombonne@ohsu.edu.

Beth Langhorst (B)

Center for Spoken Language Understanding, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97221, USA. Electronic address: calame@ohsu.edu.

Joel Nigg (J)

Department of Psychiatry, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97221, USA. Electronic address: niggj@ohsu.edu.

Damien A Fair (DA)

Department of Behavioral Neuroscience, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97221, USA; Advanced Imaging Research Center, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97221, USA. Electronic address: faird@ohsu.edu.

Eric Feczko (E)

Department of Behavioral Neuroscience, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97221, USA; Department of Medical Informatics and Clinical Epidemiology; Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97221, USA. Electronic address: feczko@ohsu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH